APA (7th ed.) Citation

E, V., R, V., AP, D., S, G., M, G., R, S., . . . N, C. (2019). Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis. Alimentary pharmacology & therapeutics, 50(3), 317. https://doi.org/10.1111/apt.15331

Chicago Style (17th ed.) Citation

E, Vilar-Gomez, Vuppalanchi R, Desai AP, Gawrieh S, Ghabril M, Saxena R, Cummings OW, and Chalasani N. "Long-term Metformin Use May Improve Clinical Outcomes in Diabetic Patients with Non-alcoholic Steatohepatitis and Bridging Fibrosis or Compensated Cirrhosis." Alimentary Pharmacology & Therapeutics 50, no. 3 (2019): 317. https://doi.org/10.1111/apt.15331.

MLA (9th ed.) Citation

E, Vilar-Gomez, et al. "Long-term Metformin Use May Improve Clinical Outcomes in Diabetic Patients with Non-alcoholic Steatohepatitis and Bridging Fibrosis or Compensated Cirrhosis." Alimentary Pharmacology & Therapeutics, vol. 50, no. 3, 2019, p. 317, https://doi.org/10.1111/apt.15331.